This year's Top 10 companies were selected from a record number of companies by reviewers from NTEC's scientific and advisory boards"
Dallas, Texas (PRWEB) September 30, 2011
EndoSphere Inc., a medical technology company developing a platform of endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes, today announced news that EndoSphere was named a "Top 10" presenting company for the MEDVENTURES 2011 annual conference for the medical technology industry. The conference will be held October 6, 2011. EndoSphere was the only company from its region selected to the Top 10. EndoSphere will be represented at MEDVENTURES by Chairman Christopher Thorne and CEO James T. McKinley
“EndoSphere is pleased to be recognized by these industry leaders as a Top 10 company for MEDVENTURES 2011,” said McKinley. “We believe that our strong patent position, in combination with promising clinical results, makes EndoSphere an attractive company in the rapidly growing fields of interventional gastroenterology and obesity treatments.”
EndoSphere invented the noninvasive SatiSphere™ duodenal insert, a medical device that uses the body’s natural physiology to manage appetite and achieve satiety. The small device is completely reversible, repeatable, and incisionless.
MEDVENTURES is an annual investment and educational conference for the rapidly growing medical technology industry. The annual conference includes investor panel discussions, healthcare policy updates, and presentations by top emerging medical technology companies. MEDVENTURES 2011 will be held in Frisco, Texas. The industry conference is organized annually by the North Texas Enterprise Center for Technology (NTEC), a leading nonprofit organization dedicated to emerging medical technology enterprises.
"NTEC received a record 70 applications and our 30 volunteer reviewers from our scientific and business advisory boards selected the Top 10 companies," said Dr. Hubert Zajicek, Managing Director - Medical Technology.
About EndoSphere Inc.
Founded in 2006, EndoSphere Inc. is a medical technology company that develops and commercializes a platform of endoscopically implantable devices for the treatment of metabolic diseases, including one of the most critical healthcare issues in the world today: obesity and its co-morbidities. The company holds 23 U.S. and international issued and pending patents. EndoSphere is a portfolio company of Broadline Capital, a global private equity investment firm led by Christopher Thorne. For more information about EndoSphere, please visit http://www.EndoSphereInc.com.
# # #